<DOC>
	<DOCNO>NCT02394314</DOCNO>
	<brief_summary>A Phase 1 , single dose study 8 cohort ascend dos design evaluate safety pharmacokinetics MEDI0382 healthy volunteer .</brief_summary>
	<brief_title>A Phase 1 , Single Dose Study Evaluate Safety Pharmacokinetics MEDI0382 Healthy Volunteers</brief_title>
	<detailed_description>This first-time-in-humans ( FTIH ) , randomize , double-blind study design evaluate safety , tolerability , PK MEDI0382 administer single-ascending SC dose healthy subject ( age 18-45 ) . Eight subject per cohort enrol total 8 cohort . The decision whether dose escalate base upon data review Dose Escalation Committee ( DEC ) . Within cohort , subject randomize MEDI0382 placebo ( 3:1 ) . Following screening , study duration subject approximately 29 day , consist inpatient evaluation period , outpatient follow-up period .</detailed_description>
	<criteria>Healthy Volunteers , age 1845 Must provide write informed consent BMI &gt; 22 &lt; 30 kg/m2 body weight &gt; 70kg Venous access suitable multiple cannulation Vital sign within normal specified range Females must nonlactating nonchildbearing potential Males must practice 2 effective contraceptive measure sexually active Any concurrent condition opinion investigator would interfere evaluation investigational product History presence gastrointestinal , renal , hepatic disease condition know interfere absorption , distribution , metabolism , excretion drug History cancer , exception nonmelanoma skin cancer Any clinically important illness , medical/surgical procedure , trauma within 4 week prior dose Positive Hepatitis B , Hepatitis C HIV test use antiretroviral medication screen . Concurrent previous use GLP1 receptor agonist Current previous use systemic corticosteroid within past 28 day prior screen Use medicinal product herbal preparation license control body weight appetite prohibit . Known suspected history alcohol drug abuse within past 3 year . Positive drug screen Current smoker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>MEDI0382 , diabetes</keyword>
</DOC>